Emilien Loeuillard

747 total citations
15 papers, 479 citations indexed

About

Emilien Loeuillard is a scholar working on Surgery, Cancer Research and Molecular Biology. According to data from OpenAlex, Emilien Loeuillard has authored 15 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 6 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Emilien Loeuillard's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), MicroRNA in disease regulation (5 papers) and Liver Disease Diagnosis and Treatment (3 papers). Emilien Loeuillard is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), MicroRNA in disease regulation (5 papers) and Liver Disease Diagnosis and Treatment (3 papers). Emilien Loeuillard collaborates with scholars based in United States, France and Belarus. Emilien Loeuillard's co-authors include Sumera I. Ilyas, Gregory J. Gores, Caitlin B. Conboy, Jingchun Yang, Rondell P. Graham, Haidong Dong, Rory L. Smoot, Chen Wang, Daniel R. O’Brien and EeeLN H. Buckarma and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Hepatology.

In The Last Decade

Emilien Loeuillard

14 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emilien Loeuillard United States 9 223 216 152 115 101 15 479
Guo‐He Lin China 10 107 0.5× 266 1.2× 103 0.7× 118 1.0× 82 0.8× 37 427
Ralf Jesenofsky Germany 12 143 0.6× 258 1.2× 95 0.6× 105 0.9× 67 0.7× 21 452
Noëlla Blétard Belgium 9 157 0.7× 102 0.5× 49 0.3× 131 1.1× 80 0.8× 27 429
Naohiko Kohya Japan 13 216 1.0× 170 0.8× 43 0.3× 191 1.7× 59 0.6× 27 449
Feiling Feng China 15 211 0.9× 178 0.8× 65 0.4× 334 2.9× 278 2.8× 37 628
Zunqiang Xiao China 13 82 0.4× 99 0.5× 95 0.6× 242 2.1× 205 2.0× 33 512
Yugang Wu China 14 71 0.3× 286 1.3× 238 1.6× 113 1.0× 85 0.8× 28 497
Laura Torrens Spain 5 117 0.5× 144 0.7× 38 0.3× 85 0.7× 75 0.7× 6 340
Irene Lo China 7 71 0.3× 147 0.7× 123 0.8× 198 1.7× 142 1.4× 9 467
Binghai Zhou China 13 66 0.3× 129 0.6× 126 0.8× 207 1.8× 175 1.7× 24 499

Countries citing papers authored by Emilien Loeuillard

Since Specialization
Citations

This map shows the geographic impact of Emilien Loeuillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilien Loeuillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilien Loeuillard more than expected).

Fields of papers citing papers by Emilien Loeuillard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilien Loeuillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilien Loeuillard. The network helps show where Emilien Loeuillard may publish in the future.

Co-authorship network of co-authors of Emilien Loeuillard

This figure shows the co-authorship network connecting the top 25 collaborators of Emilien Loeuillard. A scholar is included among the top collaborators of Emilien Loeuillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilien Loeuillard. Emilien Loeuillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Yan, Irene K., Emilien Loeuillard, Nathan W. Werneburg, et al.. (2025). Aptamer-directed, nanovesicle-mediated targeting of undruggable molecules in preclinical cholangiocarcinoma models. Hepatology. 82(5). 1090–1111.
2.
Li, Binbin, Jingchun Yang, Emilien Loeuillard, et al.. (2024). Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinoma. Journal of Hepatology. 80(6). 892–903. 12 indexed citations
3.
Parthasarathy, Gopanandan, Amy S. Mauer, Emilien Loeuillard, et al.. (2024). Macrophage RAGE activation is proinflammatory in NASH. JCI Insight. 9(3). 7 indexed citations
4.
Loeuillard, Emilien, et al.. (2024). Rethinking Immune Check Point Inhibitors Use in Liver Transplantation: Implications and Resistance. Cellular and Molecular Gastroenterology and Hepatology. 19(1). 101407–101407. 2 indexed citations
5.
Loeuillard, Emilien, Binbin Li, Jingchun Yang, et al.. (2024). Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Growth in Cholangiocarcinoma. Cellular and Molecular Gastroenterology and Hepatology. 17(5). 853–876. 6 indexed citations
6.
Loeuillard, Emilien, Juan Wang, Jingchun Yang, et al.. (2022). Abstract P072: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) foster myeloid-derived suppressor cell-mediated tumor immune evasion in cholangiocarcinoma. Cancer Immunology Research. 10(1_Supplement). P072–P072. 1 indexed citations
7.
Wang, Juan, Emilien Loeuillard, Gregory J. Gores, & Sumera I. Ilyas. (2021). Cholangiocarcinoma: what are the most valuable therapeutic targets – cancer-associated fibroblasts, immune cells, or beyond T cells?. Expert Opinion on Therapeutic Targets. 25(10). 835–845. 12 indexed citations
8.
Loeuillard, Emilien, Jingchun Yang, Haidong Dong, Gregory J. Gores, & Sumera I. Ilyas. (2021). Abstract 2738: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediates tumor immune evasion in cholangiocarcinoma. Cancer Research. 81(13_Supplement). 2738–2738. 1 indexed citations
9.
Loeuillard, Emilien, Jingchun Yang, EeeLN H. Buckarma, et al.. (2020). Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma. Journal of Clinical Investigation. 130(10). 5380–5396. 232 indexed citations
10.
Loeuillard, Emilien, Caitlin B. Conboy, Gregory J. Gores, & Sumera I. Ilyas. (2019). Immunobiology of cholangiocarcinoma. JHEP Reports. 1(4). 297–311. 87 indexed citations
11.
Loeuillard, Emilien, Haquima El Mourabit, Lin Lei, et al.. (2018). Endoplasmic reticulum stress induces inverse regulations of major functions in portal myofibroblasts during liver fibrosis progression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(12). 3688–3696. 18 indexed citations
12.
Loeuillard, Emilien, et al.. (2018). Animal models of cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(5). 982–992. 59 indexed citations
13.
Mourabit, Haquima El, Emilien Loeuillard, Sara Lemoinne, Axelle Cadoret, & Chantal Housset. (2016). Culture Model of Rat Portal Myofibroblasts. Frontiers in Physiology. 7. 120–120. 11 indexed citations
14.
Melchior, Chloé, Emilien Loeuillard, Rachel Marion‐Letellier, et al.. (2014). Magnetic Resonance Colonography for Fibrosis Assessment in Rats with Chronic Colitis. PLoS ONE. 9(7). e100921–e100921. 13 indexed citations
15.
Loeuillard, Emilien. (2014). 2,4,6-trinitrobenzene sulfonic acid-induced chronic colitis with fibrosis and modulation of TGF-β1 signaling. World Journal of Gastroenterology. 20(48). 18207–18207. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guo‐He Lin Breakdown of academic impact, for papers by Ralf Jesenofsky Breakdown of academic impact, for papers by Noëlla Blétard Breakdown of academic impact, for papers by Naohiko Kohya Breakdown of academic impact, for papers by Feiling Feng Breakdown of academic impact, for papers by Zunqiang Xiao Breakdown of academic impact, for papers by Yugang Wu Breakdown of academic impact, for papers by Laura Torrens Breakdown of academic impact, for papers by Irene Lo Breakdown of academic impact, for papers by Binghai Zhou
Rankless by CCL
2026